EverQuote

EVER · NASDAQ

$22.72+$0.52 (+2.34%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $22.20

EVER analyst rating

BuyConsensus of 6 analysts over the last 12 months. 100% rate it a buy.

Strong buy0
Buy6
Hold0
Underperform0
Sell0

12-month price target · 8 analysts

Average $30.19 (+32.9% upside)

Low: $28.28
Now: $22.72
High: $35.70

Upgrades and downgrades

The latest rating actions, newest first

EVER analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
JP Morgan	Aug 24, 2026	Initiates	Overweight	$29.00	27%
B. Riley Securities	Aug 4, 2026	Maintains	Buy	$30.00 → $34.00	56%
Needham	Aug 4, 2026	Maintains	Buy	$25.00 → $30.00	45%
JP Morgan	May 5, 2026	Maintains	Overweight	$22.00 → $24.00	46%
Needham	May 5, 2026	Maintains	Buy	$25.00	45%
JP Morgan	Feb 24, 2026	Maintains	Overweight	$32.00 → $22.00	46%
Canaccord Genuity	Feb 24, 2026	Maintains	Buy	$33.00 → $28.00	52%
B. Riley Securities	Feb 24, 2026	Maintains	Buy	$36.00 → $30.00	49%
Needham	Feb 24, 2026	Maintains	Buy	$40.00 → $25.00	45%
JP Morgan	Dec 12, 2025	Maintains	Overweight	$30.00 → $32.00	46%

The case for and against

Updated Aug 13, 2026

Bull case

EverQuote is expected to continue experiencing strong growth and profitability as insurance carriers reactivate marketing campaigns, increase their focus on winning customers, and grow market share. The company's high-intent, pre-validated consumer referrals, aligned with insurers underwriting and profitability requirements, coupled with its transparency and campaign management tools, make it a compelling choice for insurance providers looking to improve their marketing spend performance and ROI. Additionally, EverQuote's data and technology platform, coupled with its direct network of insurance providers, position it for sustained success in the rapidly growing digital insurance marketplace.

Bear case

EverQuote is a promising company with potential for long-term growth due to its strong execution and expanding carrier demand. However, there are risks associated with its heavy reliance on the auto insurance market and possible customer concentration, as exhibited by one customer making up 39% of its revenue in 2024. Additionally, the current trading price of EVER shares, at an EV/FY27E EBITDA multiple of ~3x, may not accurately reflect its future growth potential, leading to a downward adjustment in PT from $36 to $30.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.